Market Cap | 1.62B | P/E | - | EPS this Y | 16.10% | Ern Qtrly Grth | - |
Income | -103.71M | Forward P/E | -19.78 | EPS next Y | 22.30% | 50D Avg Chg | 3.00% |
Sales | 176.58M | PEG | -1.85 | EPS past 5Y | - | 200D Avg Chg | -2.00% |
Dividend | N/A | Price/Book | 10.45 | EPS next 5Y | 23.10% | 52W High Chg | -31.00% |
Recommedations | 1.70 | Quick Ratio | 6.37 | Shares Outstanding | 51.93M | 52W Low Chg | 42.00% |
Insider Own | 4.94% | ROA | -21.19% | Shares Float | 49.58M | Beta | 1.03 |
Inst Own | 88.07% | ROE | -50.88% | Shares Shorted/Prior | 5.70M/5.67M | Price | 36.00 |
Gross Margin | 54.73% | Profit Margin | -58.73% | Avg. Volume | 475,209 | Target Price | 88.50 |
Oper. Margin | -50.28% | Earnings Date | Oct 30 | Volume | 2,014,766 | Change | 6.13% |
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
TD Cowen | Buy | Sep 16, 24 |
Truist Securities | Buy | Sep 3, 24 |
B of A Securities | Buy | Aug 22, 24 |
Wells Fargo | Overweight | Aug 2, 24 |
Truist Securities | Buy | Aug 2, 24 |
Truist Securities | Buy | Jul 16, 24 |
TD Cowen | Buy | May 6, 24 |
Piper Sandler | Overweight | May 6, 24 |
Truist Securities | Buy | May 2, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Jan 09 | Sell | 44.97 | 16,000 | 719,520 | 47,351 | 01/11/24 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Jan 09 | Option | 4.56 | 16,000 | 72,960 | 63,351 | 01/11/24 |
Waters Kevin | EVP, CFO EVP, CFO | Jan 09 | Sell | 45.07 | 17,310 | 780,162 | 33,523 | 01/11/24 |
Waters Kevin | EVP, CFO EVP, CFO | Jan 09 | Option | 4.52 | 17,310 | 78,241 | 50,833 | 01/11/24 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Dec 14 | Sell | 42.96 | 15,000 | 644,400 | 46,933 | 12/15/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Dec 14 | Option | 4.56 | 15,000 | 68,400 | 58,729 | 12/15/23 |
Waters Kevin | EVP, CFO EVP, CFO | Dec 13 | Sell | 40.05 | 71,465 | 2,862,173 | 33,523 | 12/15/23 |
Waters Kevin | EVP, CFO EVP, CFO | Dec 13 | Option | 4.52 | 71,465 | 323,022 | 104,988 | 12/15/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Dec 06 | Sell | 39.96 | 6,096 | 243,596 | 46,933 | 12/08/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Dec 06 | Option | 4.52 | 6,096 | 27,554 | 53,029 | 12/08/23 |
Waters Kevin | EVP, CFO EVP, CFO | Dec 06 | Sell | 40.01 | 15,085 | 603,551 | 33,523 | 12/08/23 |
Waters Kevin | EVP, CFO EVP, CFO | Dec 06 | Option | 4.52 | 15,085 | 68,184 | 48,608 | 12/08/23 |
MOLL FREDERIC H | Director Director | Dec 06 | Sell | 38.87 | 79,000 | 3,070,730 | 808,233 | 12/08/23 |
Wood Morgan Colby | Director Director | Nov 13 | Sell | 32.1924 | 25,000 | 804,810 | 112,425 | 11/14/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Jul 27 | Sell | 40 | 7,903 | 316,120 | 46,933 | 07/31/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Jul 27 | Option | 4.52 | 7,903 | 35,722 | 54,836 | 07/31/23 |
Waters Kevin | EVP, CFO EVP, CFO | Jun 15 | Sell | 35.1249 | 22,631 | 794,912 | 33,523 | 06/15/23 |
Zadno Reza | President, CEO President, CEO | Apr 28 | Option | 4.37 | 19,995 | 87,378 | 195,808 | 05/02/23 |
Zadno Reza | President, CEO President, CEO | Apr 04 | Option | 4.37 | 20,022 | 87,496 | 175,813 | 04/05/23 |
Waters Kevin | EVP, CFO EVP, CFO | Mar 07 | Sell | 34.56 | 30,000 | 1,036,800 | 56,860 | 03/09/23 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | Mar 08 | Option | 4.52 | 10,000 | 45,200 | 35,114 | 03/09/23 |
Krummel Thomas M | Director Director | Jun 21 | Option | 3.45 | 20,000 | 69,000 | 102,920 | 06/22/22 |
Krummel Thomas M | Director Director | Jun 21 | Sell | 35.76 | 20,000 | 715,200 | 82,920 | 06/22/22 |
Nouri Alaleh | EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. | May 16 | Sell | 35.06 | 678 | 23,771 | 46,468 | 05/16/22 |
VIKING GLOBAL INVESTORS LP | 10% Owner 10% Owner | Mar 18 | Sell | 29.9 | 1,249,000 | 37,345,100 | 298,205 | 03/22/22 |
Wood Morgan Colby | Director Director | Mar 11 | Buy | 24.4262 | 940 | 22,961 | 147,713 | 03/14/22 |